Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07008911 · ClinicalTrials.gov registry record · NA
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
A NA study of Aortic Valve Stenosis and Aortic Valve Disease, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07008911 is a NA study of Aortic Valve Stenosis and Aortic Valve Disease that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 200 participants, below the 1,037-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07008911, a NA study of Aortic Valve Stenosis and Aortic Valve Disease, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health using wearable devices and a digital engagement platform. A total of 200 patients will be recruited from the UCHealth Structural Heart and Valve Clinic and randomized to either CardioHeartConnect or CardioHeartEd. Participants will be assessed at baseline, 8 weeks, and 12 months using surveys, smartwatch data, and electronic health records.
Conditions Studied
Interventions
- BEHAVIORAL CardioHeartConnect
- BEHAVIORAL CardioHeartEd
Study Locations (1)
Colorado
- UCHealth Structural Heart and Valve Clinic - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07008911
The ClinicalTrials.gov registry entry for NCT07008911 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,037-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (81% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 2 interventions - of which CardioHeartConnect is the first listed.
NCT07008911 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT07008911 about?
NCT07008911 is a clinical study titled "CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation". This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activ...
What is the current status of trial NCT07008911?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-09-30. Estimated completion is 2029-08-01.
What conditions does trial NCT07008911 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis, Aortic Valve Disease.
What interventions are being tested in trial NCT07008911?
The interventions under investigation include: CardioHeartConnect (BEHAVIORAL), CardioHeartEd (BEHAVIORAL).
Who is sponsoring clinical trial NCT07008911?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07008911 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
MRI in Transcatheter Aortic Valve Replacement Patients
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
-
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
RECRUITING · NA
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.